Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
225,970,109
-
Total 13F shares
-
207,903,581
-
Share change
-
-1,406,577
-
Total reported value
-
$90,580,448,880
-
Put/Call ratio
-
121%
-
Price per share
-
$435.42
-
Number of holders
-
1,517
-
Value change
-
-$638,821,702
-
Number of buys
-
668
-
Number of sells
-
665
Institutional Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q3 2023
As of 30 Sep 2023 Elevance Health, Inc. - Common Stock (ELV) had 1,517 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 207,903,581 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, GEODE CAPITAL MANAGEMENT, LLC, Sanders Capital, LLC, FMR LLC, ALLIANCEBERNSTEIN L.P., and AMERIPRISE FINANCIAL INC.
This table shows 1,517 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.